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Abstract
Background: Although the incidence of breast cancer is lower in African-American women than in White women,
African-American women have a decreased survival rate. The difference in survival rate may stem from poor endocrine therapy
adherence, which increases breast cancer recurrence. Therefore, accessible and culturally sensitive interventions to increase
endocrine therapy adherence are necessary.
Objective: The purpose of this concurrent convergent mixed methods study was to provide further data to guide the development
of the proposed culturally sensitive mHealth app, STORY+ for African-American women with breast cancer.
Methods: We recruited 20 African-American women diagnosed with estrogen-positive breast cancer and currently prescribed
endocrine therapy. We used a concurrent convergent data collection method to (1) assess the use of smartphones and computers
related to health care and (2) identify foundational aspects to support endocrine therapy adherence for incorporation in a mobile
health app.
Results: Overwhelmingly, the participants preferred using smartphones to using computers for health care. Communicating
with health care providers and pharmacies was the most frequent health care use of smartphones, followed by exercise tracking,
and accessing the patient portal. We identified 4 aspects of adherence to endocrine therapy and smartphone use for incorporation
in app development. The factors that emerged from the integrated qualitative and quantitative data were (1) willingness to use,
(2) side effects, (3) social connection, and (4) beliefs about endocrine therapy.
Conclusions: Further research is needed to develop a culturally sensitive app for African-American women with breast cancer
to improve adherence to endocrine therapy. Our work strongly suggests that this population would use the app to connect with
other African-American breast cancer survivors and manage endocrine therapy.
(JMIR Form Res 2021;5(6):e23884) doi: 10.2196/23884
KEYWORDS
mHealth; breast cancer survivors; medication adherence; cultural considerations; mobile health applications

Introduction
Breast cancer is the second-most common cancer among women
in the United States and results in the second-highest cancer
death rates [1]. Earlier detection through screening and advances
in treatments have contributed to an increase in the 5- and
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10-year breast cancer survival rates [2]; however,
African-American women have decreased survival rates and
higher mortality rates compared to White women despite lower
incidence rates [3]. One potential explanation for the differences
in survival rates and mortality among women with
estrogen-positive breast cancer is adherence to long-term
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endocrine therapy, which may last for 5 to 10 years [4].
Endocrine therapy, which blocks estrogen receptors in breast
cancer cells, can reduce recurrence by 40% and lower the risk
of dying by one-third [5]. Overall, African-American women
have low long-term adherence rates to endocrine therapy [6,7].
Therefore, interventions to assist this vulnerable population
with endocrine therapy adherence are essential [4,8].
We conducted a literature review on interventions that improve
endocrine therapy adherence, which identified 2 consequential
gaps in existing intervention research: use of education only
interventions and a lack of cultural adaptations [9-16]. Next,
we examined commercially available cancer and medication
adherence mobile health (mHealth) apps as a possible option
to address these gaps and assist African-American women with
endocrine therapy adherence [17-21]. Unfortunately, available
cancer and medication adherence apps also have several areas
that cause concern: (1) a lack of adequate development or testing
in clinical practice [17,22,23], (2) a lack of input from patients
or providers resulting in significant usability problems [24-26],
and (3) a lack of scientifically valid information, with the
majority of cancer-related apps created to promote a pharmacy
or organization and not to assist African-American women with
endocrine therapy adherence [20,26]. Importantly, over 90% of
medication adherence mHealth apps were simple reminders and
not effective in improving adherence [20]. Cancer mHealth apps
research has explored functionality and acceptability, but only
one evaluated effectiveness or clinical outcomes [17-19].
To address these gaps in endocrine therapy adherence and
mHealth apps for medication adherence, we propose to extend
our earlier teleconferencing work, Sisters Tell Others and Revive
Yourself (STORY), a culturally tailored intervention that
connected African-American women with breast cancer to
support and educated them during initial diagnosis and treatment
[27]. We wanted to explore how STORY components could
assist endocrine therapy adherence in a more accessible platform
such as an mHealth app. The purpose of this concurrent
convergent mixed methods study [28] was to provide further
data to guide the development of the proposed culturally
sensitive mHealth app, STORY+ for African-American women
with breast cancer. Our initial work has been reported
[14,29-34]. The aims of this study were to (1) assess the use of
smartphones and computers related to health care in
African-American women with breast cancer, and (2) identify
foundational aspects to support endocrine therapy adherence
for incorporation in an mHealth app.

Methods
Overview
The concurrent convergent mixed methods design of our study
incorporated the simultaneous collection, analysis, and
interpretation of qualitative and quantitative data to inform the
design of an mHealth app to increase adherence to endocrine
therapy in African-American women with breast cancer. We
recruited 20 African-American women with a diagnosis of
estrogen-positive breast cancer and prescribed endocrine
therapy. We conducted an ex-ante study (ie, before the design
and construction of the app). Prior to the start of the study, the
https://formative.jmir.org/2021/6/e23884
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University of South Carolina Institutional Review Board
approved the study (Pro00085557).

Sampling Strategy and Inclusion Criteria
We combined 2 sampling schemes (ie, criterion and
convenience) to select our sample. These strategies followed
the works of Onwuegbuzie and Collins [35], who established
typologies for sampling designs in social science research and
suggested appropriate sample sizes. We also used design science
research criteria (ie, innovation and evolution) to establish the
legitimacy of our sample size. A sample of 20 or fewer for
formative research is often employed [36,37]. We needed
women who met our enrollment criteria, but we wanted
heterogeneity in the sample. We used a random number
generator to select potential participants for recruitment from
a pool of 1577 patients. We reviewed the potential participants’
medical records and selected the first 50 patients who met the
inclusion criteria. This process created our first batch of potential
participants. From previous recruitment efforts, we had
estimated that 50 potential participants would supply our
recruitment goal of 20 participants. We planned to recruit until
we reached informational redundancy [38,39] (ie, both
qualitative and quantitative data provided no new information).
If the initial batch did not supply sufficient participants, the
process was to be repeated, and data collection would be
continued.
Inclusion criteria were African-American women who were 18
years of age or older, had been diagnosed with estrogen-positive
breast cancer in the past 10 years, were currently prescribed
endocrine therapy, and were able to speak and understand
English. Reading English was not a requirement because the
researcher read the informed consent and questions to the
participants. Exclusion criteria were individuals with a diagnosis
of psychosis, with significant cognitive impairment, or
undergoing current treatment for another cancer excluding
squamous cell (any type).

Recruitment and Retention
Women who were eligible based on the inclusion and exclusion
criteria were recruited through a comprehensive oncology
outpatient practice in South Carolina (500 new breast cancer
patients annually). Our recruitment plan was covered by a Health
Information Portability and Accountability Act waiver with the
oncology outpatient cancer physician practice. We used the
Heiney-Adams Recruitment Framework to guide our recruitment
efforts [40]. The principal investigator mailed a personal letter
to potential participants with a colorful and readable frequently
asked questions flyer using the STORY logo (designed by focus
group participants in STORY). Within 5 days of the mailing, a
racially concordant researcher contacted participants by
telephone. The researcher followed a script that asked if the
patient had a diagnosis of estrogen-positive breast cancer and
had been prescribed tamoxifen or an aromatase inhibitor. To
improve recruitment and retention in the study, participants
received a gift card for their time and effort. We successfully
recruited 20 patients. From the original list of 50 potential
participants, 19 could not be reached by phone or mail, 7
declined to participate, 2 did not meet the criteria, and 2 were
not contacted because accrual was reached (Figure 1).
JMIR Form Res 2021 | vol. 5 | iss. 6 | e23884 | p. 2
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Figure 1. Study flow diagram.

Data Collection
The research team, which included nurses and software
computer engineers, developed a data collection tool using
Research Electronic Data Capture (REDCap [41]; Vanderbilt
University). The data collection tool consisted of a qualitative
interview guide (Multimedia Appendix 1) and quantitative
(open- and closed-ended) questions (Multimedia Appendix 2).
Data collection, which we digitally recorded, began with
structured questions and ended with semistructured questions.
The researcher pilot tested the REDCap data collection tool
with 1 African-American breast cancer survivor before the data
collection process, resulting in minor adjustments of the tool
based upon the feedback. This pilot testing established the ease
of data collection using REDCap during an interview, not
reliability or validity.
Once the researcher received verbal consent from the participant
during the telephone conversations, she scheduled the
assessment appointment at the participant’s choice of location,
usually in the home or a meeting room in the local library.
During this assessment appointment, the researcher (1) read all
interview questions to the participant, (2) recorded the responses
directly in the REDCap data collection tool via a tablet for the
quantitative questions, and (3) digitally recorded the qualitative
interview questions and participants’ responses. A professional
transcriptionist transcribed the deidentified recordings verbatim.

Data Analysis
Quantitative Data

standard deviations, and ranges. For categorical variables, we
calculated frequencies and percentages.

Qualitative Data
We used thematic analysis [42]. No software was used to
analyze the qualitative data. Briefly, data analysis began by
listening to the digital recordings of participant responses to the
semistructured interview questions. Next, 2 researchers read
and reread the transcripts and began open line by line coding
of the data. We coded significant and salient phrases and words
within each transcript. We identified and discussed themes from
these codes until consensus was reached.

Data Integration
For clarity, we organized the findings by aim. Most findings
are reported with quantitative data and supporting qualitative
quotes [39]. In some instances, qualitative themes emerged that
were not explored in the quantitative questions and vice versa.
In these cases, the results are displayed separately.

Results
Sample Description
Participants’ (n=20; age: mean 59 years, SD 10) mean length
of time diagnosed with breast cancer was 4 years (Table 1).
Most participants had stage 1A breast cancer (9/20, 45%). Over
50% of participants (11/20) were prescribed tamoxifen, which
did not change during their treatment period. The length of time
on endocrine therapy was evenly split between more than 2
years (10/20, 50%) and 2 years or less (10/20, 50%).

We exported the data from REDCap into Excel (Microsoft Inc)
for analysis. For continuous variables, we calculated means,

https://formative.jmir.org/2021/6/e23884
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Table 1. Participant characteristics.
Characteristics

Value, n (%)

Age (years)
Mean (SD)

59 (10)

Range

46-82

Length of time since diagnosis/recurrencea (years)
Mean (SD)

4 (4)

Range

1-17

Stage of breast cancer
0

4 (20)

1A

9 (45)

1B

2 (10)

2A

1 (5)

2B

2 (10)

3A

1 (5)

4

1 (5)

Medications
Tamoxifen

11 (55)

Anastrozole

8 (40)

Letrazole

1 (5)

Length of time on medication
<2 years

10 (50)

>2 years

10 (50)

Always prescribed same medication

a

Yes

14 (70)

No

6 (30)

One patient experienced recurrence within the past 5 years.

Smartphone and Computer Use for Health Care
Overwhelmingly, the participants preferred using a smartphone
for health care over using a computer.

https://formative.jmir.org/2021/6/e23884
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I pretty much do everything on my cell phone because
it’s always with me. [Participant 13]
With respect to health care use, participants reported
communicating with health care providers and pharmacies most
frequently, followed by exercise tracking, and accessing the
patient portal (Table 2).
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Table 2. Smartphone and computer use for health care.
Use

Communicate with health
care provider

Quantitative data

Qualitative data

Smartphone, n (%) Computer, n (%)

Quotations

15 (75)

2 (10)

“... sometimes my provider will send me a message or tell me they put
something out on the portal for me to go and check.” [Participant 14]

0 (0)

”My pharmacist will contact me via text mail.”[Participant 7]

Communicate with pharmacy 13 (65)

“The prompt I got today from [the pharmacy] was that I needed a refill and
would I allow them to call my doctor. Of course which I said yes.” [Participant
12]
Exercise tracking, coaching,
or management

7 (35)

0 (0)

“The only health aid I use is a Fitbit to help keep up with my steps. I’m supposed to make at least 10,000 steps per day.” [Participant 13]
“I got an Engage app from my job with my insurance and stuff. It is a program
we have on the job. Well, I went through the program with a dieting thing.
It was to help you lose weight and it sets you up. They send you a scale. You
weigh every day. They give you a coach. She logs in every day with different
ideas and stuff for you to do meals to plan and it also helps, but my insurance
will come down instead of paying a surcharge.” [Participant 18]

Patient portal

7 (35)

7 (35)

“I use my patient portal...” [Participant 1]
”But I do a lot on my phone. If I want to check my medical records, I go to
the patient portal for the various organizations that have my medical records
where I can check.” [Participant 19]

Connect or manage wearables 5 (25)

0 (0)

“I’m just mainly [monitor] with my Fitbit.” [Participant 5]
“I use the Fitbit...” [Participant 19]

Medication management or
reminders

2 (10)

Diet tracking, coaching, or
management

1 (5)

0 (0)

“Just the pharmacy’s [app] for my medication reminders.” [Participant 13]
“I feel if I ever took that reminder off my phone that I will miss one [medication dose]...”[Participant 4]

3 (15)

“...Samsung app for fitness. You can put your food diet, your food thing in
it. It counts your calories, your steps, your pulse, and all of that. And it’s the
app that automatically comes with a Samsung phone.”[Participant 1]
“Well, I went through the program with a dieting thing. It was to help you
lose weight and it sets you up. They send you a scale. You weigh every day.
They give you a coach. She logs in every day with different ideas and stuff
for you to do meals to plan and it also helps, but my insurance will come
down instead of paying a surcharge.” [Participant 20]

Personal health records
a

1 (5)

2 (10)

—a

A representative quotation is not available.

Factors
Overview
We identified 4 aspects of endocrine therapy adherence and
smartphone use that may guide app development. The factors
that emerged from the integrated qualitative and quantitative
data included (1) willingness to use, (2) side effects, (3) social
connection, and (4) beliefs about endocrine therapy.

Willingness to Use an App for African-American Breast
Cancer Survivors
The majority of participants (17/20, 85%) stated that they would
use an mHealth app to assist with endocrine therapy adherence.
They specifically mentioned an online community of other
breast cancer survivors and African-American–tailored graphics
(ie, emojis, videos). The qualitative interviews provided
additional details on the importance of an app for
African-American breast cancer survivors:

https://formative.jmir.org/2021/6/e23884
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On the [majority] of apps, I see it is still [for] white
[women]. I don’t normally see too many blacks that
I can reach out to. I would love to share with an
African-American female [with breast cancer] what
I’ve been through. Every app that I [see] dealing with
breast cancer shows white [women], and I would love
to talk to African-American women, women of color.
[Participant 9]
I think the other thing is, when people see people like
them, not like they’re not out there, because they are,
then they’d be more apt to reach out. [Participant 19]
It seems like a lot of women that have it [breast
cancer] are ashamed to tell other women about it
[breast cancer] and you’re in the dark when you get
it [breast cancer]. The only time you find out about
it [breast cancer] is when you’re in a conversation
and you say, oh, I had breast cancer, then she’ll share
hers [diagnosis] with you. But other than that, they
[women] don’t like to say this, open with their answer.
JMIR Form Res 2021 | vol. 5 | iss. 6 | e23884 | p. 5
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No, and so to see that and then see what other women
are going through it’ll help me too. [Participant 8]
I feel like with my story...Sharing it [my story] with
others... it [sharing my story] might brighten their
day or it might help them to understand that just
because you had cancer it’s nothing to be ashamed
of. [Participant 10]

Self-Reported Side Effects
In patients’ self-reported experiences (ie, reports were not
verified by health care providers) with the side effects of
endocrine therapy (Table 3), almost one-third (6/20, 30%) of
participants stated that they called their health care provider
about the side effects, with 15% (3/20) reporting they made an
appointment with the health care provider to discuss the side
effects. In addition, 80% (16/20) of participants talked with a
family member, friend, or significant other about the side effects.

Table 3. Self-reported endocrine therapy side effects.
Side effect

Quantitative data,
n (%)

Quotations

Hot flashes

17 (85)

“So, sometimes I put a cool towel around my neck, but it’s just, I just get hot around the neck. It’s
like I’m on fire.” [Participant 13]
“I’ve been using a lot of air-conditioning. But it [hot flash] doesn’t last long, and I usually get it like
once a day. At any time. And it will last about like 15 minutes and then it’s gone.” [Participant 6]

Bone/joint pain

13 (65)

“I actually had to get referrals for some of the pain. I actually had to end up going to the orthopedic.
I had problems with my left hand. The pain, I couldn’t hold anything [in my left hand] and I was in
severe pain.” [Participant 5]
“So, then you look up like, all right, God, my joints are hurting, what the hell?” [Participant 12]

Fatigue or lack of energy 11 (55)

“The biggest problem I had with side effects, the fatigue I would try to kind of pace myself when I’m
doing certain things especially after coming home from work instead of just getting right into it doing
some laundry or doing, I kind of take a break.” [Participant 14]

Weight gain

“I have gained much weight. I hate it [weight gain].” [Participant 17]

11 (55)

“I can deal with the weight gain because I can continue to walk and it just helps me see the nature
outside,...” [Participant 4]
Hair thinning

10 (50)

“...I did experience, um, hair thinning.” [Participant 14]

Increased sweating

10 (50)

—a

Mood swings

10 (50)

—

Leg cramps

9 (45)

—

Dry skin and/or eyes

7 (35)

—

Insomnia

7 (35)

“...some nights I sleep five hours and some, but I know if I got at least six to seven hours that was a
good night’s sleep for me because there are times when I’m say, but if I’m up at night...” [Participant
14]

Loss of sex drive

7 (35)

“God, I gotta have an orgasm, this is ridiculous. This is pissing me off. That almost made me quit.”
[Participant 12]
“I do have to say that I was gonna talk to my doctor about, you know, anything she can do with the
part that comes to like my loss of sex drive, like, that bothers me a lot because I know, like, I know
my husband, not that anything is wrong.” [Participant 4]

a

Constipation

6 (30)

—

Depression

5 (25)

“When I started, the depression almost made me quit. For sure. Because I’m not a depressed person.”
[Participant 12]

Vaginal dryness

5 (25)

—

Vision problems

5 (25)

—

Back pain

4 (20)

“Like I said, when I get up in the morning my back hurts me, but I go to a 9:30 class at Rec Center,
so by the time I’ve exercised it’s not hurting me as much. I was leaving there [Rec Center] and going
two times per week for the dry needling and stuff and that has helped...” [Participant 15]

Dizziness

4 (20)

“It, um, you do get a little dizzy with them because taking this medicine. I mean, I think any hormone
medicine will make you feel a little woozy at times. Um, it’s not, it’s not every day though. I don’t
have it every day. I have it every now and then.” [Participant 8]

A representative quotation is not available.
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Beliefs About the Value of Endocrine Therapy
There were many motivators, especially external motivators,
for patients to continue endocrine therapy. The most prominent
motivators for endocrine therapy adherence included the desire
to live longer (16/20); children (16/20); and religion, church,
or a higher being (15/20). Other motivators included friends
(13/20), extended family (13/20), and significant others (11/20).
Both quantitative and qualitative data demonstrated similar
themes in motivators to endocrine therapy adherence, including
increased mortality and living for family.
I must say life. Because if I didn’t take it [endocrine
therapy] then that would make my body more [likely]
to [have] what I’ve had in the past. So, when it was
told for me to take it this is what I needed to do and
that is what I’m doing. So, I’m gonna say life.
[Participant 9]
I take it [endocrine therapy] because they say I need
to take it with the medicine because of my situation
with the breast cancer. They say I have to take that.
I didn’t want to take it because I said I felt like it
wasn’t helping me. And she [the doctor] said, well,
yeah you need to take that. You have to continue
taking that. So, I’m just saying like they say I gotta
take it [endocrine therapy]...Because it’s gonna help
me with my situation. I’m gonna do what I gotta do
for me. [Participant 3]
Well, I was told that it [endocrine therapy] would
keep the cancer away. It’s a tool, I guess it’s
considered as a chemo agent to keep your hormonal
level down. That’s what was explained to me.
[Participant 13]
Well, I know I have to take it [endocrine therapy] for
the next five years. That’s part of my treatment. I know
it’s part of my treatment, so I’m willing to do
whatever is necessary to follow the treatment plan.
[Participant 6]
My family. My grandson. My son. I only have one
child and he’s everything to me and my grandson he gives me life. My grandson gave me life. I got
diagnosed the year that he was born, so it was like,
oh no, no, no, no, no, I gots to be here for him.
[Participant 4]

Social Connections
Qualitative and quantitative data supported the importance of
connecting with other African-American women with breast
cancer. Participants valued digital social connections and
face-to-face interactions. They used smartphones to connect
and interact with other individuals including survivors with
85% (17/20) using smartphones for communication (ie, phone
calls, email, texting). Participants used smartphones for instant
messaging (12/20, 60%) and video chat (11/20, 55%). Facebook
was the most popular social media platform among the
participants, with 65% (13/20) accessing Facebook via
smartphones and computers. Instagram was the next popular
social media platform with 25% (5/20) accessing Instagram via
smartphone and 15% (3/20) accessing Instagram via computer.
https://formative.jmir.org/2021/6/e23884
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Interviews with the participants substantiated the variety of
ways African-American women with breast cancer connected
and their importance in the breast cancer survivor journey.
Participants discussed the need for connecting with other
African-American breast cancer survivors and described
supportive interactions.
We talk a lot because actually in my job it was quite
a few of us that were diagnosed in a short period of
time. [Participant 1]
We have a group, we still hang together after 52, 53
years, two of my friends, my classmates had already
had breast cancer, so I certainly reached out to them
to talk to them, and that helped, so that was it.
[Participant 5]
Well, I only have a few people I connect with and we
all work in the same department. We [are] all in it
with the same type of cancer. [Participant 13]
I’d like to see what other women, African-American
women are going through and see if, you know, if
we’re all going through the same thing or if it’s, you
know, different. [Participant 2]
It’s [Livestrong Program] through the Y[MCA] and
that’s a program that you should share with other
African-American women. I was the only
African-American woman that was in it. [Participant
15]
But, when you talk to people, you really want support
not sympathy. A person can empathize with you... But
not sympathy and you need someone that’s going to
be strong in the support when you are talking to them.
[Participant 5]
Find their support system whether it be family, group
meetings and there’s a bunch of them out there...
Church, co-workers. I had all of that. Definitely, don’t
try to go through it alone. Have your support system.
That’s the most important thing because there’s gonna
be days you just feel like, why me. I mean, there’s just
gonna be those days. That’s all I can say. You need
somebody to talk to, talk to them. [Participant 17]

Discussion
General
This concurrent convergent mixed methods study provides
additional data to guide the development of STORY+. We
assessed the use of smartphones and computers related to health
care in the targeted population and identified foundational
mHealth features to support endocrine therapy adherence.
Overall, the participants used smartphones more frequently than
they used computers for health care, especially for social
interactions such as social media, messaging, and email. This
finding suggests that African-American breast cancer survivors
are more likely to use an mHealth app than they are to use a
webpage via computer to assist with endocrine therapy
adherence. Overwhelmingly, African-American breast cancer
survivors use smartphones in managing their health through

JMIR Form Res 2021 | vol. 5 | iss. 6 | e23884 | p. 7
(page number not for citation purposes)

JMIR FORMATIVE RESEARCH

Donevant et al

communication with their health care provider and pharmacy
to promote their health.

adherence and social connections with other African-American
breast cancer survivors.

While fewer participants reported using mHealth apps for
medication tracking and health care record management,
qualitative results indicated that combining social and cultural
features with mHealth functions would be desirable. Other
researchers have also identified the need for racial and cultural
content [43-49]. Our study verifies that African-American
women do not have a culturally sensitive mechanism to track
symptoms and discuss symptoms with health care providers.
We concluded that foundational STORY+ features should
include the following: an online community of other
African-American breast cancer survivors, tailored graphics,
information about prescribed endocrine therapy and its potential
side effects, and a method for tracking side effects, sharing the
frequency and severity of side effects, and recording medication
adherence. Previous findings [50] have also supported the use
of interactive features to promote positive health
outcomes—participants overwhelmingly supported the
development of an mHealth app to assist with endocrine therapy

Limitations
The study is not generalizable beyond the immediate needs of
the research team; however, the results of this study provide a
foundation for the mHealth app development, STORY+. The
literature suggests that other breast cancer survivors experience
similar endocrine therapy side effects [51].

Conclusions
This concurrent convergent mixed methods study established
the use of smartphones by African-American breast cancer
survivors for health care management. We also identified
foundational features for STORY+. This work recognizes that
one app does not fit all needs and advances the science of
cultural and racial appropriate mHealth apps. Future work will
include the development and testing of STORY+ for
African-American breast cancer survivors to promote endocrine
therapy adherence.
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